Clinical Trial Update: SB-773812 Administered In Adults With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial of SB-773812 in adults with schizophrenia has completed (status: COMPLETED). GlaxoSmithKline is the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SB-773812

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED